About Balamurali Ambati
Balamurali Ambati is a board member at Inflammasome Therapeutics.
Balamurali Ambati first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Balamurali Ambati in the role, so the role may have started earlier or lasted longer.
Inflammasome Therapeutics, Inc.
Board Member
2023 – 2026 · Newton, MA
Develops experimental drugs for people with eye and degenerative diseases.
Key Colleagues at Startups
The people Balamurali Ambati works with at each company, as listed on that company's latest Form D.
Inflammasome Therapeutics, Inc. · Form D, May 4, 2026
Jayakrishna Ambati
Co-Founder and Board Member
Chaniyilparampu Ramchand
Board Member
Babur Lateef
Chairman of the Board
Napoleone Ferrara
Board Member